Atlas FDA

Neuspera Sacral Neuromodulation System

FDA premarket approval P240031/S001 · decided 2025-08-15

Approval details

PMA number
P240031
Supplement
S001
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Neuspera Sacral Neuromodulation System
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Neuspera Medical, Inc.
Date received
2025-07-18
Decision date
2025-08-15
Days to decision
28 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
San Jose, CA
Statement
approval of the protocol for the post-approval study (PAS) of Neuspera Sacral Neuromodulation System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Neuspera Nuity System (K221303)Neuspera Medical, Inc.2023-04-11
Neuspera Neurostimulation System (NNS) (K202781)Neuspera Medical, Inc.2021-08-27